# Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.

> **NCT00172198** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 30 (—)

## Conditions studied

- Critical Ill Patients in SICU

## Interventions

- **DRUG:** Omegaven 10%

## Key facts

- **NCT ID:** NCT00172198
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172198, "Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00172198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*